Warrant holders paid approximately $1,963,967 in gross proceeds on May 12, 2026 under an incentive program. The company also raised its stockholder meeting quorum to one-third to match Nasdaq rules.
The prospectus registers resale shares only, so the company gets no proceeds from those sales. It expects Nasdaq trading on or about May 21, 2026, and its own financials carry going-concern doubt.
Questions about Conexeu Sciences
Has Conexeu Sciences issued a going-concern warning?
Our latest story on this, dated May 11, 2026: "Conexeu Sciences registers 9,481,123 shares for resale ahead of planned Nasdaq listing". The story links the filing or release it is based on. Read the story.
What is the ticker symbol of Conexeu Sciences?
Conexeu Sciences Inc. trades under the ticker CNXU on NASDAQ.
Where is Conexeu Sciences listed?
Conexeu Sciences Inc. is listed on NASDAQ.
What is the SEC CIK of Conexeu Sciences?
The SEC Central Index Key (CIK) for Conexeu Sciences Inc. is 2066836. Its filings are on SEC EDGAR.
How many shares does Conexeu Sciences have outstanding?
28,206,698 shares as of 2026-09-10, per the cover page of its 10-Q filed 2026-09-14.
Which country or territory is Conexeu Sciences listed under?
Our directory records Conexeu Sciences Inc. under United States.
What does Conexeu Sciences do?
Our directory classifies Conexeu Sciences Inc. as: Biotechnology. This is a directory classification, not a description of the pipeline.
What is the ISIN of Conexeu Sciences?
The ISIN recorded for Conexeu Sciences Inc. is US20715F1003.
Does aibio.space cover Conexeu Sciences?
aibio.space lists Conexeu Sciences Inc. among 2,820 public biotech companies and publishes its news here as stories appear.
Where is Conexeu Sciences incorporated?
SEC records list its state or country of incorporation as NV.
What is the latest Conexeu Sciences (CNXU) stock news?
Our latest story on Conexeu Sciences, dated May 15, 2026: "Conexeu Sciences issues 4,342,648 shares on warrant exercises for about $1,963,967". Warrant holders paid approximately $1,963,967 in gross proceeds on May 12, 2026 under an incentive program. The company also raised its stockholder meeting quorum to one-third to match Nasdaq rules. Source.
What is Conexeu Sciences's latest stock offering or financing news?
Our latest financing story, dated May 15, 2026: "Conexeu Sciences issues 4,342,648 shares on warrant exercises for about $1,963,967". Warrant holders paid approximately $1,963,967 in gross proceeds on May 12, 2026 under an incentive program. The company also raised its stockholder meeting quorum to one-third to match Nasdaq rules. Source.
Who were the underwriters or placement agents on Conexeu Sciences's offering?
From our story: It names H.C. Wainwright & Co., LLC as the company's financial advisor. Source.
How long will Conexeu Sciences's cash last?
From our story of May 11, 2026: It expects Nasdaq trading on or about May 21, 2026, and its own financials carry going-concern doubt. Source.
Is Conexeu Sciences a smaller reporting company?
SEC records list Conexeu Sciences Inc.'s filer category as: <br>Emerging growth company.
Investor discussion: Conexeu Sciences
Members talk about Conexeu Sciences (CNXU). Reader posts, not aibio.space reporting, and not investment advice.
Rules
Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.
Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.
Capital-markets timeline
Financings, listing notices, splits, legal actions and other investor events at Conexeu Sciences, newest first. Each line links the filing it comes from.
Distress
Reported substantial doubt about its ability to continue as a going concern. SEC Form 10-Q. Source
Financings
Reported an unregistered sale of its securities. SEC Form 424B4. Source
Stock chart
Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open NASDAQ:CNXU on TradingView.
Source: SEC EDGAR, retrieved October 23, 2026. Shares outstanding is the cover-page figure from the latest periodic report. The SEC does not publish share prices.
Listing details
Conexeu Sciences Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker CNXU, recorded under United States. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.
Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.
Published and maintained by aibio.space. Not investment advice. How we work.
Who manages this pageThis page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction
aibio